ALSO NOTED: EU panel recommends Bayer, GSK drugs; Novacea names new CEO; and much more...

> An EMEA advisory panel has issued six positive opinions on marketing applications for new drugs, paving the way for EU marketing approval. Report

> Chutes & Ladders: Novacea has elected John P. Walker as CEO. He will continue to serve the Chairman of the company. Release

> Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases has won the Lasker Prize. Report

> Millipore is expanding on its reputation as a filtration supplier to scientific labs around the globe. Report

> Generics may be the bane of Big Pharma, but they're inflation-fighting ninjas. Over the last 12 months, prescription drug prices edged up by a measly 1 percent--the lowest rate of inflation in three decades. Report

> Pfizer is looking to set up its Japanese R&D operation, previously slated for shutdown, as an independent company--with the help of a few investors, of course. Report

And Finally... An ancient mechanism for coping with stresses also gives cancer a boost. Release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

Pfizer's eczema hopeful has been building its case to challenge Sanofi and Regeneron's Dupixent, but safety issues could stand in its way.

Cedrik Britten, M.D., becomes the biotech’s new chief medical officer to help run its adoptive cell therapy and TCR bispecifics platform.